Spectral Medical (TSE:EDT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Spectral Medical Inc. has successfully closed an additional US$1 million offering of convertible notes to a major shareholder, bolstering the company’s financial position as it advances the Tigris trial for its PMX treatment for septic shock. The proceeds will support the ongoing Phase III trial and general corporate needs. This move reflects the shareholder’s confidence in the company during a critical phase of development.
For further insights into TSE:EDT stock, check out TipRanks’ Stock Analysis page.